January 12, 2023
Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
6min
• The European Commission approved QDENGA (TAK-003) for use in individuals four years of age and older • QDENGA becomes the only dengue vaccine approved in the EU for use in individuals regardless of previous dengue exposure Colombo, December 28, 2022 – Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) granted […]